Perkins Capital Management’s Neuronetics STIM Stock Holding History

Perkins Capital Management’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$37.4K	Buy	+16,000	New	+$39.3K	0.03%	85

Other funds holding STIM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

VestGen Advisors Inverness, Illinois $3.25B AUM 30.95% 1-Year Est. Return

T3 Companies New York $103M AUM 54.73% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Perkins Capital Management's STIM Position: Q3 2026 in Review

Perkins Capital Management opened a new position in Neuronetics (STIM) in Q3 2026: 16,000 shares worth $37.4K. The stake represents 0.03% of the portfolio and ranks #85 among its holdings.

21 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

Perkins Capital Management held 16,000 shares of Neuronetics worth $37.4K as of Q3 2026.
Neuronetics was a new Perkins Capital Management position in Q3 2026.
Neuronetics made up 0.03% of Perkins Capital Management's portfolio in Q3 2026, its #85 holding.
21 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Perkins Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.